Caribou Biosciences (CRBU) Short-term Investments (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Short-term Investments data on file, last reported at $105.6 million in Q1 2026.

• On a quarterly basis, Short-term Investments fell 41.04% year-over-year to $105.6 million in Q1 2026; TTM through Mar 2026 was $105.6 million, a 41.04% decrease from a year earlier, with the FY2025 full-year figure at $127.0 million, down 34.29% from the prior year.
• Short-term Investments for Q1 2026 stood at $105.6 million, down from $127.0 million in the prior quarter.
• Over the last five years, Short-term Investments for CRBU reached as high as $277.7 million in Q4 2023 and fell as low as $105.6 million in Q1 2026.
• Historically, Short-term Investments has averaged $192.9 million across 5 years, with a median of $193.2 million in 2024.
• Across the five-year window, Short-term Investments jumped 46.66% in 2023 and sank 41.04% in 2026, its largest moves.
• Year by year, Short-term Investments stood at $189.3 million in 2022, then surged by 46.66% to $277.7 million in 2023, then plunged by 30.4% to $193.2 million in 2024, then plunged by 34.29% to $127.0 million in 2025, then dropped by 16.86% to $105.6 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $105.6 million in Q1 2026, $127.0 million in Q4 2025, and $136.1 million in Q3 2025.